Associations between glucocorticoid use and major adverse cardiovascular events in patients with prostate cancer receiving antiandrogen: a retrospective cohort study
Prednisolone/prednisone coadministration with abiraterone likely contributed to abiraterone-related increased cardiovascular risk. Prevalent cumulative glucocorticoid dose was associated with cardiovascular risk.
Authors
- Chi‐Ho Leung (ORCID: https://orcid.org/0000-0001-5484-9390)
- Gary Tse (ORCID: https://orcid.org/0000-0001-5510-1253)
- Kenrick Ng (ORCID: https://orcid.org/0000-0001-9132-4075)
- Yan Hiu Athena Lee (ORCID: https://orcid.org/0000-0003-0740-1598)
- Edward Christopher Dee (ORCID: https://orcid.org/0000-0001-6119-0889)
- Jeffrey Shi Kai Chan (ORCID: https://orcid.org/0000-0003-0231-2393)
- Chi‐Fai Ng (ORCID: https://orcid.org/0000-0002-1723-9646)
- David Ka Wai Leung
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Electric Power Research Institute (US)
- Chinese University of Hong Kong (HK)
- University of Kent (GB)
- Second Hospital of Tianjin Medical University (CN)
- Tianjin Medical University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Prostate Cancer and Prostatic Diseases
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1038/s41391-024-00889-x
- Citations
- 5
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Cancer Institute